Loading provider…
Loading provider…
Epilepsy Physician in Maryland Heights, MO
NPI: 1356478705Primary Practice Location
RANKEN JORDAN PEDIATRIC BRIDGE HOSPITAL
11365 Dorsett Rd, Maryland Heights, MO
Primary Employer
Washington University School of Medicine
surgery.wustl.edu
HQ Phone
Get MD Robin's Phone Numberphone_androidMobile
Get MD Robin's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
IL State Medical License
2020 - 2026
MO State Medical License
2011 - 2026

American Board of Psychiatry and Neurology
Neurology with Special Qualification in Child Neurology

American Board of Psychiatry and Neurology
Epilepsy
Mass General Brigham/Massachusetts General Hospital
Fellowship • Child Neurology
2008 - 2011
Residency • Pediatrics
2006 - 2008
Vanderbilt University School Of Medicine
medschool.vanderbilt.edu
Medical School
Until 2006
Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndrome.
Authors: Elizabeth Berry-Kravis, David Lieberman, Cary Fu, Colleen Buhrfiend, Alan Percy, Timothy Benke, Mona Darwish, Amitha Ananth, James Youakim, Jeffrey Neul, Timothy Feyma
Journal: Med
Publication Date: 2025-03-04
From Serendipity to Scalability in Rare Disease Patient Collaborations.
Authors: Judith Weisenberg
Journal: Mo Med
Developing the Pediatric Refractory Epilepsy Questionnaire: a pilot study.
Authors: Vaishnavi Purusothaman, David Limbrick, Matthew Smyth
Journal: Epilepsy Behav
Publication Date: 2014-06-23
Lead Sponsor: University of Alabama at Birmingham
Collaborators: National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Advancing Translational Sciences (NCATS), Office of Rare Diseases (ORD)
Lead Sponsor: University of Alabama at Birmingham
Collaborators: National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Advancing Translational Sciences (NCATS), Rare Diseases Clinical Research Network
Lead Sponsor: ACADIA Pharmaceuticals Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: Trofinetide